CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (4,916)	$ (165)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	128	123
Amortization	6
Interest expense - debt discount	1,239
Accretion of original issue discount on notes receivable - related party	(36)
Interest expense on conversion of demand notes to common stock	13
Stock-based compensation	1,269	129
Changes in operating assets and liabilities:
Accounts receivable	(737)	82
Inventories	228	243
Prepaid expenses and other current assets	(166)	(60)
Other assets	(197)
Accounts payable and accrued expenses	2,083	(101)
Accounts payable, related parties	104
Other current liabilities	(595)	(113)
Net cash (used in) provided by operating activities	(1,577)	138
Cash flows from investing activities:
Purchase of property and equipment	(22)	(78)
Purchase of intangible asset	(50)
Purchase of Power-Plus	(409)
Sale of investment		90
Investments - related party	(2,710)
Investment in real property	(300)
Investments - others	(25)
Loans to related parties	(54)
Loans to third parties	(814)
Net cash (used in) provided by investing activities	(4,384)	12
Cash flows from financing activities:
Gross proceeds from sales of common stock and warrants	745
Proceeds from issuance of preferred stock	1,540
Financing cost in connection with sales of equity securities	(275)
Proceeds from convertible notes payable	1,514
Payments on convertible notes payable	(157)
Proceeds from notes payable - related party	350
Proceeds from notes payable	785
Payments on notes payable	(30)
Proceeds from advances on future receipts	1,772
Payments on advances on future receipts	(439)
Payments of preferred dividends	(8)
Financing cost in connection with sales of debt securities	(122)
Payments on revolving credit facilities, net	(481)
Net cash provided by financing activities	5,194
Effect of exchange rate changes on cash and cash equivalents	85	(99)
Net (decrease) increase in cash and cash equivalents	(682)	51
Cash and cash equivalents at beginning of period	996	1,241
Cash and cash equivalents at end of period	314	1,292
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	69
Non-cash investing and financing activities:
Cancellation of notes payable - related party into shares of common stock	100
Cancellation of notes payable into shares of common stock	$ 648
Cancellation of note payable - related party into series B convertible preferred stock	500
Cancellation of convertible note payable into shares of common stock	$ 145
In connection with the Company's acquisition of Microphase Corporation, equity instruments were issued and liabilities assumed during 2017 as follows:
Fair value of assets acquired	7,893
Equity instruments issued	(1,451)
Minority interest	(945)
Liabilities assumed	$ 5,497